Stable mixed hematopoietic chimerism in DLA-identical littermate dogs given sublethal total body irradiation before and pharmacological immunosuppression after marrow transplantation.
暂无分享,去创建一个
H. Deeg | J Wagner | R. Storb | W. Leisenring | H. Kiem | C. Yu | R. Nash | H. Shulman | J. Wagner | H. Kiem | Cong Yu | C. Yu | C. Yu
[1] R. Storb,et al. Molecular analysis of DLA-DRBB1 polymorphism. , 1996, Tissue antigens.
[2] E. Ostrander,et al. Histocompatibility testing of dog families with highly polymorphic microsatellite markers. , 1996, Transplantation.
[3] J. Scott,et al. Bone marrow transplantation for sickle cell disease. , 1996, The New England journal of medicine.
[4] D. Sachs,et al. Additional monoclonal antibody (mAB) injections can replace thymic irradiation to allow induction of mixed chimerism and tolerance in mice receiving bone marrow transplantation after conditioning with anti-T cell mABs and 3-Gy whole body irradiation. , 1996, Transplantation.
[5] M. Sykes,et al. Mechanism by which additional monoclonal antibody (mAB) injections overcome the requirement for thymic irradiation to achieve mixed chimerism in mice receiving bone marrow transplantation after conditioning with anti-T cell mABs and 3-Gy whole body irradiation. , 1996, Transplantation.
[6] M. Sykes,et al. Natural killer cells weakly resist engraftment of allogeneic, long-term, multilineage-repopulating hematopoietic stem cells. , 1996, Transplantation.
[7] H. Schlitt,et al. Development, stability, and clinical correlations of allogeneic microchimerism after solid organ transplantation. , 1996, Transplantation.
[8] S. Boggs,et al. Mixed allogeneic chimerism induced by a sublethal approach prevents autoimmune diabetes and reverses insulitis in nonobese diabetic (NOD) mice. , 1996, Journal of immunology.
[9] H. Gritsch,et al. Combined simultaneous kidney/bone marrow transplantation. , 1995, Transplantation.
[10] R. Wiesner,et al. Organ-specific patterns of donor antigen-specific hyporeactivity and peripheral blood allogeneic microchimerism in lung, kidney, and liver transplant recipients. , 1995, Transplantation.
[11] H. Deeg,et al. DLA-identical bone marrow grafts after low-dose total body irradiation: effects of high-dose corticosteroids and cyclosporine on engraftment. , 1995, Blood.
[12] Y. Colson,et al. A nonlethal conditioning approach to achieve durable multilineage mixed chimerism and tolerance across major, minor, and hematopoietic histocompatibility barriers. , 1995, Journal of immunology.
[13] F. Obata,et al. Factors influencing long-term operational tolerance in dogs treated with fractionated lymphoid irradiation, donor bone marrow cell infusion and FK506. , 1995, Transplantation proceedings.
[14] R. Colvin,et al. Mixed Allogeneic Chimerism And Renal Allograft Tolerance In Cynomolgus Monkeys , 1995, Transplantation.
[15] E. Bryant,et al. USE OF (CA)n POLYMORPHISMS TO DETERMINE THE ORIGIN OF BLOOD CELLS AFTER ALLOGENEIC CANINE MARROW GRAFTING , 1994, Transplantation.
[16] T. Starzl,et al. CHIMERISM AND DONOR‐SPECIFIC NONREACTIVITY 27 TO 29 YEARS AFTER KIDNEY ALLOTRANSPLANTATION , 1993, Transplantation.
[17] H. Deeg,et al. Marrow toxicity of fractionated vs. single dose total body irradiation is identical in a canine model. , 1993, International journal of radiation oncology, biology, physics.
[18] M. Andreani,et al. Mixed chimerism in thalassemic patients after bone marrow transplantation. , 1992, Bone marrow transplantation.
[19] U. Varanasi,et al. Storage phosphor imaging technique for detection and quantitation of DNA adducts measured by the 32P-postlabeling assay. , 1992, Carcinogenesis.
[20] D. Danilenko,et al. Monoclonal antibodies specific for canine CD4 and CD8 define functional T-lymphocyte subsets and high-density expression of CD4 by canine neutrophils. , 1992, Tissue antigens.
[21] T. Starzl,et al. Cell migration, chimerism, and graft acceptance , 1992, The Lancet.
[22] D. Sachs,et al. Mixed allogeneic chimeras prepared by a non-myeloablative regimen: requirement for chimerism to maintain tolerance. , 1992, Bone marrow transplantation.
[23] H. Waldmann,et al. Monoclonal antibodies to promote marrow engraftment and tissue graft tolerance , 1986, Nature.
[24] H. Deeg,et al. Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia. , 1986, The New England journal of medicine.
[25] R. Storb,et al. Mixed Hematologic Chimerism After Allogeneic Marrow Transplantation for Severe Aplastic Anemia Is Associated With a Higher Risk of Graft Rejection and a Lessened Incidence of Acute Graft-Versus-Host Disease , 1986 .
[26] H. Deeg,et al. CYCLOSPORIN A AND METHOTREXATE IN CANINE MARROW TRANSPLANTATION: ENGRAFTMENT, GRAFT‐VERSUS-HOST DISEASE, AND INDUCTION OF TOLERANCE , 1982, Transplantation.
[27] H. Ochs,et al. Immunologic Reactivity in Canine Marrow Graft Recipients , 1974, The Journal of Immunology.
[28] R. Prehn,et al. Successful skin homografts after the administration of high dosage X radiation and homologous bone marrow. , 1955, Journal of the National Cancer Institute.